Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sid Topiol

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Future Medicinal Chemistry|March 24, 2018
New opportunities for GPCR allosteric modulatorsSid Topiol
Expert Opinion on Drug Discovery|March 30, 2013
X-ray structural information of GPCRs in drug design: what are the limitations and where do we go?Sid Topiol
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2017
Current and Future Challenges in GPCR Drug DiscoverySid Topiol
Journal of Medicinal Chemistry|June 5, 2018
A Surprising Recipe for Designing Biased LigandsSid Topiol
Biochemical Pharmacology|May 19, 2009
X-ray structure breakthroughs in the GPCR transmembrane regionSid Topiol, Michael Sabio
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Use of the X-ray structure of the Beta2-adrenergic receptor for drug discoverySid Topiol, Michael Sabio
Bioorganic & Medicinal Chemistry Letters|December 27, 2015
7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5Sid Topiol, Michael Sabio
Expert Opinion on Drug Discovery|July 28, 2015
The role of experimental and computational structural approaches in 7TM drug discoverySid Topiol, Michael Sabio
Chemical Biology & Drug Design|October 11, 2008
Driving forces for ligand migration in the leucine transporterAnne Marie Jørgensen, Sid Topiol
Bioorganic & Medicinal Chemistry Letters|October 3, 2008
Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compoundsMichael Sabio, Kenneth Jones, Sid Topiol
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Future Medicinal Chemistry|March 24, 2018
New opportunities for GPCR allosteric modulatorsSid Topiol
Expert Opinion on Drug Discovery|March 30, 2013
X-ray structural information of GPCRs in drug design: what are the limitations and where do we go?Sid Topiol
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2017
Current and Future Challenges in GPCR Drug DiscoverySid Topiol
Journal of Medicinal Chemistry|June 5, 2018
A Surprising Recipe for Designing Biased LigandsSid Topiol
Biochemical Pharmacology|May 19, 2009
X-ray structure breakthroughs in the GPCR transmembrane regionSid Topiol, Michael Sabio
Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Use of the X-ray structure of the Beta2-adrenergic receptor for drug discoverySid Topiol, Michael Sabio
Bioorganic & Medicinal Chemistry Letters|December 27, 2015
7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5Sid Topiol, Michael Sabio
Expert Opinion on Drug Discovery|July 28, 2015
The role of experimental and computational structural approaches in 7TM drug discoverySid Topiol, Michael Sabio
Chemical Biology & Drug Design|October 11, 2008
Driving forces for ligand migration in the leucine transporterAnne Marie Jørgensen, Sid Topiol
Bioorganic & Medicinal Chemistry Letters|October 3, 2008
Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compoundsMichael Sabio, Kenneth Jones, Sid Topiol
Pageof 2